EphB4 inhibitors (Northwestern University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEphB4 inhibitors (Northwestern University)
Drug Alias NameEphrin type-B receptor 4 inhibitors (Northwestern University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEphrin type-B receptor 4 antagonists
TargetsEphrin type-B receptor 4
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorthwestern University
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A